On October 31, 2006, BioForm Medical, Inc. announced a licensing and distribution agreement with CryoLife, Inc. for the development and commercialization of CryoLife's proprietary BioGlue Surgical Adhesive for use in cosmetic and plastic surgery indications.

On June 26, 2007, CryoLife, Inc. and BioForm Medical, Inc. announced that the first patient had been enrolled in a clinical study evaluating BioGlue Surgical Adhesive as a method of fixation in brow lifts.  BioForm is currently conducting a feasibility study under an investigational device exemption, or IDE, from the FDA.

BioForm's strategy is to determine compelling aesthetics applications for BioGlue, demonstrate safety and effectiveness of this material in aesthetics applications, and launch BioGlue as an alternative fixation methodology to improve browplasty and certain other surgical and minimally invasive aesthetics procedures.  To learn more about BioForm Medical visit www.bioformmedical.com.